| Abstrakt: |
Such antibodies are also prone to binding with other antibodies of the same type and, in the process, forming thick solutions that don't flow easily through the needles that deliver antibody drugs. Changing the amino acids that comprise an antibody, and in turn the antibody's 3D structure, could prevent antibodies from misbehaving because an antibody's structure determines what it can bind. Keywords: Antibodies; Blood Proteins; Chemical Engineering; Chemicals; Cyborgs; Emerging Technologies; Engineering; Health and Medicine; Immunoglobulins; Immunology; Machine Learning; Pharmaceutical Sciences; Proteins; Therapy; University of Michigan EN Antibodies Blood Proteins Chemical Engineering Chemicals Cyborgs Emerging Technologies Engineering Health and Medicine Immunoglobulins Immunology Machine Learning Pharmaceutical Sciences Proteins Therapy University of Michigan 248 248 1 09/25/23 20230929 NES 230929 2023 SEP 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Images Antibody treatments may be able to activate the immune system to fight diseases like Parkinson's, Alzheimer's and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren't markers of disease. [Extracted from the article] |
